Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier